Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.

about

Withaferin A inhibits the proliferation of gastric cancer cells by inducing G2/M cell cycle arrest and apoptosis.Oxidative stress-induced JNK/AP-1 signaling is a major pathway involved in selective apoptosis of myelodysplastic syndrome cells by Withaferin-A.

P2860

Q40978388-80D12FB9-618C-4569-B4E0-7BEDFF10DF7E Q43480924-418ACE0C-7016-4862-8636-801654091282

P2860

Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.

Item

http://www.wikidata.org/entity/Q38764079

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Withaferin A suppresses the gr ...... biting cell cycle progression.

@en

type

Item

label

Withaferin A suppresses the gr ...... biting cell cycle progression.

@en

prefLabel

Withaferin A suppresses the gr ...... biting cell cycle progression.

@en

P1476

Withaferin A suppresses the gr ...... biting cell cycle progression.

@en

P2093

Jun-Ichiro Kida

http://www.w3.org/2001/XMLSchema#string

Kaoru Tohyama

http://www.w3.org/2001/XMLSchema#string

Shin-Ichiro Suemori

http://www.w3.org/2001/XMLSchema#string

Shuichiro Okamoto

http://www.w3.org/2001/XMLSchema#string

Takayuki Tsujioka

http://www.w3.org/2001/XMLSchema#string

Toshinori Kondo

http://www.w3.org/2001/XMLSchema#string

Yumi Tohyama

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin

Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy

Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis

Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.

Autophagy is a survival mechanism of acute myelogenous leukemia precursors during dual mTORC2/mTORC1 targeting

An autophagy inhibitor enhances the inhibition of cell proliferation induced by a proteasome inhibitor in MCF-7 cells.

Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.

Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells

Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.

P304

1302-1314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12988

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27311589

http://www.w3.org/2001/XMLSchema#string

P932

5021033

http://www.w3.org/2001/XMLSchema#string

Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.

about

P2860

P2860

Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932